Pabau GO app

The new Pabau GO is heredownload on the App Store

Download on the App Store
Book a demo Book a demo
Diagnostic Codes

ICD-10 code H02.79: Other degenerative eyelid disorders

Key takeaways

Key takeaways

ICD-10 Code H02.79 describes other degenerative disorders of the eyelid and periocular area and is a valid, billable FY2026 diagnosis code.

H02.79 sits under parent code H02.7 within Chapter 7 (Diseases of the eye and adnexa, H00-H59) and covers named conditions not captured by H02.70.

The ICD-9-CM equivalent is 374.56; coders transitioning legacy claims should verify the approximate crosswalk before submitting.

Pabau’s claims management software helps ophthalmology and oculoplastic practices capture H02.79 accurately and reduce claim denials.

ICD-10 code H02.79 is a billable diagnosis code for other degenerative disorders of the eyelid and periocular area. It applies to named conditions, such as eyelid elastosis, that don’t fit a more specific code within the H02.7x subcategory – and it’s the code ophthalmology and oculoplastic practices should reach for instead of defaulting to the unspecified H02.70.

This reference covers the clinical description and billable status of H02.79, its position in the ICD-10-CM code hierarchy, the ICD-9-CM crosswalk, related adjacent codes, documentation requirements, and commonly paired CPT codes.

ICD-10 Code H02.79: Definition and billable status

Claims management software used in ophthalmology settings needs to flag when a coder defaults to an unspecified code. H02.79 is precisely the code that prevents that default in eyelid degenerative disorder cases. According to the Centers for Medicare and Medicaid Services (CMS), H02.79 is a valid, billable ICD-10-CM diagnosis code for the 2026 fiscal year.

Automate claims through Healthcode
Automate claims through Healthcode

The full clinical description is: Other degenerative disorders of eyelid and periocular area. It applies to degenerative conditions affecting the eyelid skin, subcutaneous tissue, or periocular region that are not captured by more specific named codes within the H02.7x subcategory.

FieldDetail
CodeH02.79
DescriptionOther degenerative disorders of eyelid and periocular area
Billable statusYes – valid FY2026 billable code
Code systemICD-10-CM (International Classification of Diseases, 10th Revision, Clinical Modification)
ChapterChapter 7: Diseases of the eye and adnexa (H00-H59)
BlockH00-H05: Disorders of eyelid, lacrimal system and orbit
Parent codeH02.7: Other and unspecified degenerative disorders of eyelid and periocular area
ICD-9-CM crosswalk374.56: Other degenerative disorders of skin affecting eyelid (approximate)

Code hierarchy and parent codes for H02.79

Understanding where H02.79 sits in the ICD-10-CM classification structure helps coders verify they’re selecting the right level of specificity – the same principle applies to related eyelid codes like H01.9, unspecified inflammation of eyelid. The code descends from the following hierarchy:

  • H00-H59: Diseases of the eye and adnexa (Chapter 7)
  • H00-H05: Disorders of eyelid, lacrimal system and orbit (block)
  • H02: Other disorders of eyelid (category)
  • H02.7: Other and unspecified degenerative disorders of eyelid and periocular area (subcategory)
  • H02.70: Unspecified degenerative disorders of eyelid and periocular area
  • H02.71: Chloasma of eyelid and periocular area
  • H02.72: Madarosis of eyelid and periocular area
  • H02.73: Vitiligo of eyelid and periocular area
  • H02.79: Other degenerative disorders of eyelid and periocular area (billable)

H02.7 has five children: H02.70 (unspecified), H02.71 (chloasma of eyelid and periocular area), H02.72 (madarosis of eyelid and periocular area), H02.73 (vitiligo of eyelid and periocular area), and H02.79 (other). H02.70 is the catch-all for cases where the degenerative condition cannot be specified further.

H02.79 applies when the condition is identifiable and named, but doesn’t fall into one of the three specific sibling codes above and has no dedicated code of its own elsewhere in ICD-10-CM. None of the H02.7x codes carry a laterality subclassification – coders should not attempt to add sub-codes for right or left eye, as none exist within this subcategory.

H02.70 vs. H02.79: Key distinction

H02.70 signals that the degenerative disorder exists but the documentation does not support a more specific code. H02.79 signals that the disorder is identifiable and documented, but it belongs to a category of “other” named conditions rather than a single pinpointed entity.

The practical test: if the clinician’s note names a condition, such as elastosis of the eyelid, that doesn’t map to a more granular H02.7x code, H02.79 is the correct choice over H02.70.

Clinical conditions included under ICD-10 Code H02.79

The H02.7 subcategory covers degenerative changes to the eyelid’s structural and dermal components. H02.79 captures the named conditions within this group that don’t have their own individual ICD-10-CM code. Examples of conditions commonly coded under H02.79 include:

  • Elastosis of the eyelid: degeneration of elastic fibers in the periocular skin

Elastosis of the eyelid has no dedicated ICD-10-CM code, which is why it falls under H02.79. Several conditions that sound similar are often miscoded here but actually have their own dedicated codes: xanthelasma palpebrarum is coded under H02.6x, madarosis of the eyelid under H02.72x, vitiligo of the eyelid under H02.73x, and blepharochalasis under H02.3x.

Coders and clinicians should verify current code assignments against the CDC/NCHS ICD-10-CM web tool annually, as tabular list updates can shift these boundaries.

Pro Tip

Audit your practice’s eyelid coding before year-end. Filter claims submitted with H02.70 over the past 12 months and review the corresponding clinical notes. Where the documentation names a specific degenerative condition, H02.79 is likely the more accurate choice. Upgrading unspecified codes reduces audit exposure and can improve medical necessity documentation.

ICD-9-CM crosswalk for H02.79

Practices maintaining legacy claim data or reconciling older patient records need the ICD-9-CM equivalent. According to the WHO ICD-10 classification crosswalk and CMS conversion tables, ICD-10-CM H02.79 maps approximately to:

ICD-9-CM 374.56: Other degenerative disorders of skin affecting eyelid

This is an approximate crosswalk, not a one-to-one equivalent. The ICD-9 category 374.56 was broader in scope than the ICD-10-CM H02.7x subcategory. Coders should treat 374.56 as a starting point for legacy lookups and verify against CMS conversion tables for any payer-specific crosswalk requirements.

The ICD-10 transition introduced greater granularity across all disease categories, and eyelid disorders are no exception – codes like H53.8, other visual disturbances, show the same jump in specificity.

Reduce eyelid disorder claim denials with smarter documentation

Pabau helps ophthalmology and oculoplastic practices capture the right diagnosis codes at the point of care, link them to the correct CPT pairs, and submit cleaner claims. See how it works for your practice.

Pabau claims management for ophthalmology practices

Coders working with eyelid disorder billing will encounter several codes adjacent to H02.79. Selecting the wrong sibling code is one of the most common sources of denials in this category.

Documentation requirements for adjacent codes like H40.9 (unspecified glaucoma) and H57.89 (other specified disorders of eye and adnexa) follow similar principles: specificity and clinical note alignment are the primary drivers of accurate code selection.

CodeDescriptionRelationship to H02.79
H02.70Unspecified degenerative disorders of eyelid and periocular areaSibling code; use when condition cannot be specified
H02.71Chloasma of eyelid and periocular areaSibling code; distinct pigmentation disorder
H02.72Madarosis of eyelid and periocular areaSibling code; use for eyelash/eyebrow loss instead of H02.79
H02.73Vitiligo of eyelid and periocular areaSibling code; use for periocular depigmentation instead of H02.79
H02.6Xanthelasma of eyelidSeparate subcategory; not part of the H02.7x degenerative branch
H02.3BlepharochalasisSeparate subcategory; not part of the H02.7x degenerative branch
H02.8Other specified disorders of eyelidParent of non-degenerative specified eyelid disorders
H02.88Meibomian gland dysfunction of eyelidAdjacent; glandular dysfunction, not degenerative
H02.1Ectropion of eyelidStructural eyelid abnormality, separate category
H02.52BlepharophimosisStructural narrowing of palpebral fissure
H02.9Unspecified disorder of eyelidUse only when no other eyelid code applies
H02.81Retained foreign body in eyelidUnrelated category; trauma/foreign body context

Coders should use the AAPC Codify ICD-10-CM lookup to verify current code descriptions and any coding notes or excludes that apply to H02.79 and adjacent codes before submitting claims.

Documentation requirements and coding guidelines for H02.79

Medical necessity is the threshold every H02.79 claim must clear. Payers expect the clinical note to describe the degenerative condition explicitly: its location (upper or lower eyelid, periocular skin), its clinical characteristics, and its impact on the patient.

A generic note stating “eyelid changes” won’t support H02.79 over H02.70 in a post-payment review. Purpose-built clinical documentation software can prompt for these details automatically at the point of care.

Strong documentation for H02.79 includes:

  • Named condition (e.g., “eyelid elastosis” or another specific degenerative diagnosis not captured by a more specific code)
  • Affected site: right upper, right lower, left upper, or left lower eyelid, or periocular skin
  • Clinical description: appearance, extent, duration, and functional impact if relevant
  • Treatment or management plan referenced in the note
  • Photograph or slit-lamp findings for conditions with a visual presentation, where relevant

A structured eye exam form template helps standardize what’s captured during the visit. Practices using digital intake forms can build structured eyelid assessment templates that prompt clinicians to capture this detail at the point of consultation, cutting the delay between the clinical encounter and billing-ready documentation.

Maintaining consistent medical forms documentation across all eyelid disorder encounters also strengthens audit defensibility.

Customizable consent and intake forms
Customizable consent and intake forms

Prior authorization considerations

Prior authorization requirements for H02.79 vary by payer and procedure. Cosmetic-adjacent conditions such as xanthelasma may face scrutiny even when billed under a medical diagnosis code. Practices should check payer-specific LCD (Local Coverage Determination) policies before scheduling procedures.

The American Academy of Ophthalmology (AAO) and the American Society of Ophthalmic Plastic and Reconstructive Surgery (ASOPRS) both publish clinical guidelines that can support medical necessity narratives where prior authorization is required.

Pro Tip

Separate your cosmetic and medical eyelid encounters in your scheduling workflow. When a patient presents with a degenerative eyelid condition that could be perceived as cosmetic, confirm insurance coverage and prior authorization requirements before the appointment rather than at checkout. A structured pre-visit checklist for eyelid procedures reduces denial rates and front-desk friction.

CPT codes commonly paired with ICD-10 code H02.79

H02.79 is a diagnosis code; it must be paired with a procedure code to complete a claim. The CPT codes most frequently submitted alongside H02.79 depend on the specific treatment performed.

Diagnoses outside the H02.7x family, such as H42 (glaucoma in diseases classified elsewhere), pair with an entirely different set of CPT codes. The patient record management system used by the practice should link the diagnosis to the procedure at the encounter level.

CPT CodeDescriptionContext with H02.79
67800Excision of chalazion; singleEyelid margin lesion excision
67810Excision of chalazion; multiple, same lidMultiple eyelid lesion excision
17000Destruction of premalignant lesions, first lesionEyelid skin lesion destruction
11440Excision, benign lesion; face/ears/eyelids (0.5 cm or less)Xanthelasma or similar lesion excision
11441Excision, benign lesion; face/ears/eyelids (0.6-1.0 cm)Larger periocular lesion excision
15820Blepharoplasty, lower eyelidFunctional blepharoplasty for blepharochalasis
15821Blepharoplasty, lower eyelid with fat removalFunctional lower lid procedure
15822Blepharoplasty, upper eyelidUpper eyelid degenerative condition with functional impairment
92002Ophthalmological services, new patient, intermediateEvaluation visit with eyelid degenerative findings
92012Ophthalmological services, established patient, intermediateFollow-up visit for ongoing eyelid degenerative condition

CPT-to-ICD-10 medical necessity crosswalks should be verified for each payer. Blepharoplasty CPT codes (15820-15822) in particular require strong functional impairment documentation when billed under a degenerative eyelid diagnosis. For atypical eyelid procedures that don’t fit a listed code, CPT code 66999 (unlisted procedure, anterior segment of eye) may apply, though payers scrutinize unlisted codes closely.

Payers typically require visual field testing results or photographs demonstrating lid ptosis or skin overhang affecting superior visual field before approving functional blepharoplasty claims. A standardized blepharoplasty procedure template helps capture this documentation up front. The practice management workflow should build this documentation check into the pre-authorization step.

Coding and billing workflow for ophthalmology practices

Accurate H02.79 billing doesn’t happen at the billing stage – it starts at the clinical encounter. Ophthalmology and oculoplastic practices that integrate diagnosis capture into the clinical workflow see fewer claim errors than those that rely on a billing team to interpret loose clinical notes after the fact.

A clean billing workflow for eyelid degenerative conditions involves three stages. First, the clinician documents the named condition, affected anatomical site, and clinical characteristics during the encounter.

Second, the coder confirms the diagnosis maps to H02.79 rather than H02.70 by verifying that the note names the condition. Third, the biller pairs H02.79 with the appropriate CPT code and checks for payer-specific LCD requirements before submission.

Practices using skin clinic software with built-in clinical note templates can pre-configure eyelid assessment fields that capture the documentation needed to support H02.79. This reduces coder reliance on incomplete notes and shortens the claim review cycle.

HIPAA-compliant handling of diagnosis data throughout this workflow is also essential. See Pabau’s guide on HIPAA-compliant practice software for broader context on data handling requirements.

Conclusion

H02.79 is a straightforward billable code once you understand where it sits in the hierarchy and what it covers. The real challenge is documentation: coders can only use H02.79 when the clinical note names a specific degenerative eyelid condition. Without that specificity, H02.70 is the technically correct choice even if it’s the weaker billing option.

Pabau’s claims management software helps ophthalmology and oculoplastic practices build the documentation workflows that support accurate ICD-10 code H02.79 submission. Structured encounter forms, linked diagnosis-to-procedure pairing, and built-in payer checks connect clinical care directly to clean claims. To see how Pabau supports eyelid disorder billing in practice, book a demo.

Continue your research

Continue your research

Need a structured approach to clinical documentation for skin and eyelid conditions? Skin clinic software from Pabau provides tailored workflows for dermatology and aesthetic practices managing degenerative skin conditions.

Looking for tools to streamline intake and consent for periocular procedures? Digital intake forms let ophthalmology teams capture structured assessment data before the patient consultation begins.

Want to understand how practice management connects to billing accuracy? What is practice management software explains how integrated systems reduce the errors that cause ICD-10 claim denials.

Frequently asked questions

What is ICD-10 code H02.79 used for?

ICD-10 code H02.79 is a billable diagnosis code used to document other degenerative disorders of the eyelid and periocular area that do not fit a more specific named code within the H02.7x subcategory. The main clinical example is elastosis of the eyelid skin; similarly named conditions like xanthelasma, madarosis, and vitiligo of the eyelid have their own dedicated codes and are not coded under H02.79.

Is H02.79 a billable ICD-10 code?

Yes, H02.79 is a valid billable ICD-10-CM diagnosis code for fiscal year 2026, confirmed by CMS and the CDC/NCHS ICD-10-CM tabular list. It can be submitted on insurance claims when the clinical documentation supports a named degenerative eyelid condition not captured by a more specific code.

What is the difference between H02.70 and H02.79?

H02.70 is the unspecified code used when the degenerative eyelid condition cannot be identified further from the clinical documentation. H02.79 applies when the condition is identified and named but falls under the “other” category rather than a specific single-entity code. Accurate selection depends entirely on what the clinician’s note documents.

What was the ICD-9-CM equivalent of H02.79?

The approximate ICD-9-CM equivalent of H02.79 is 374.56 (Other degenerative disorders of skin affecting eyelid). This is an approximate crosswalk only; the ICD-9 category was broader, and coders should verify against official CMS conversion tables when reconciling legacy claims.

What CPT codes are commonly billed with H02.79?

Common CPT codes paired with H02.79 include 11440-11441 (benign lesion excision on eyelids), 67800-67810 (chalazion excision), 15820-15822 (blepharoplasty), and 92002/92012 (ophthalmological evaluation services). The correct pairing depends on the procedure performed and requires payer-specific medical necessity verification before submission.

×